132 related articles for article (PubMed ID: 1317906)
21. Vasodilatory effects of B-type natriuretic peptide are impaired in patients with chronic heart failure.
Nakamura M; Arakawa N; Yoshida H; Makita S; Niinuma H; Hiramori K
Am Heart J; 1998 Mar; 135(3):414-20. PubMed ID: 9506326
[TBL] [Abstract][Full Text] [Related]
22. Role of natriuretic peptides in regulation of conduit artery distensibility.
Schmitt M; Qasem A; McEniery C; Wilkinson IB; Tatarinoff V; Noble K; Klemes J; Payne N; Frenneaux MP; Cockcroft J; Avolio A
Am J Physiol Heart Circ Physiol; 2004 Sep; 287(3):H1167-71. PubMed ID: 15317675
[TBL] [Abstract][Full Text] [Related]
23. Decreased venous distensibility in essential hypertension: lack of systemic hemodynamic correlates.
Simon G; Franciosa JA; Cohn JN
Angiology; 1979 Mar; 30(3):147-59. PubMed ID: 373515
[TBL] [Abstract][Full Text] [Related]
24. Vasodilatory actions of alpha-human atrial natriuretic peptide and high Ca2+ effects in normal man.
Fujita T; Ito Y; Noda H; Sato Y; Ando K; Kangawa K; Matsuo H
J Clin Invest; 1987 Sep; 80(3):832-40. PubMed ID: 3040808
[TBL] [Abstract][Full Text] [Related]
25. Vasodilator responses in the forearm skin of patients with insulin-dependent diabetes mellitus.
Khan F; Cohen RA; Ruderman NB; Chipkin SR; Coffman JD
Vasc Med; 1996; 1(3):187-93. PubMed ID: 9546937
[TBL] [Abstract][Full Text] [Related]
26. Effects of L-arginine on forearm vessels and responses to acetylcholine.
Imaizumi T; Hirooka Y; Masaki H; Harada S; Momohara M; Tagawa T; Takeshita A
Hypertension; 1992 Oct; 20(4):511-7. PubMed ID: 1398886
[TBL] [Abstract][Full Text] [Related]
27. Magnesium infusion improves endothelium-dependent vasodilation in the human forearm.
Haenni A; Johansson K; Lind L; Lithell H
Am J Hypertens; 2002 Jan; 15(1 Pt 1):10-5. PubMed ID: 11824853
[TBL] [Abstract][Full Text] [Related]
28. Greater vasodilator responsiveness to atrial natriuretic peptide in low-renin essential hypertensives.
Bolli P; Müller FB; Linder L; Raine AE; Resink TJ; Erne P; Kiowski W; Bühler FR
J Hypertens Suppl; 1987 Dec; 5(5):S55-8. PubMed ID: 2965230
[TBL] [Abstract][Full Text] [Related]
29. Atrial antipressor natriuretic peptide: release mechanisms and vascular action in man.
Müller FB; Erne P; Raine AE; Bolli P; Linder L; Resink TJ; Cottier C; Bühler FR
J Hypertens Suppl; 1986 Jun; 4(2):S109-14. PubMed ID: 2941531
[TBL] [Abstract][Full Text] [Related]
30. Lack of venodilative activity of alpha human atrial natriuretic polypeptide in patients with congestive heart failure.
Ikenouchi H; Sato H; Hirata Y; Iizuka M; Serizawa T; Sugimoto T
Jpn Heart J; 1989 Jul; 30(4):443-57. PubMed ID: 2530371
[TBL] [Abstract][Full Text] [Related]
31. Estrogen and progesterone effects on transcapillary fluid dynamics.
Stachenfeld NS; Keefe DL; Palter SF
Am J Physiol Regul Integr Comp Physiol; 2001 Oct; 281(4):R1319-29. PubMed ID: 11557642
[TBL] [Abstract][Full Text] [Related]
32. Attenuated forearm vasodilator response to atrial natriuretic factor in the elderly.
Jansen TL; Smits P; Tan AC; Thien T
Hypertension; 1991 Nov; 18(5):640-7. PubMed ID: 1657770
[TBL] [Abstract][Full Text] [Related]
33. Atrial natriuretic peptide decreases hepatic and cardiac blood content, but increases intestinal blood content in supine humans.
Peters J; Neuser D; Schaden W; Arndt JO
Basic Res Cardiol; 1992; 87(3):250-62. PubMed ID: 1325772
[TBL] [Abstract][Full Text] [Related]
34. Moderate, Short-Term, Local Hyperglycemia Attenuates Forearm Endothelium-Dependent Vasodilation After Transient Ischemia-Reperfusion in Human Volunteers.
Ebert TJ; Novalija J; Barney JA; Uhrich TD; Arain SR; Freed JK; Pagel PS
J Cardiothorac Vasc Anesth; 2017 Oct; 31(5):1649-1655. PubMed ID: 28284926
[TBL] [Abstract][Full Text] [Related]
35. Effect of ANP on circulating blood volume.
Sugimoto E; Shigemi K; Okuno T; Yawata T; Morimoto T
Am J Physiol; 1989 Jul; 257(1 Pt 2):R127-31. PubMed ID: 2526591
[TBL] [Abstract][Full Text] [Related]
36. The vasodilating effect of atrial natriuretic peptide in normotensive and hypertensive humans.
Bolli P; Müller FB; Linder L; Raine AE; Resink TJ; Erne P; Kiowski W; Bühler FR
J Cardiovasc Pharmacol; 1989; 13 Suppl 6():S75-9. PubMed ID: 2473356
[TBL] [Abstract][Full Text] [Related]
37. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
Eiskjaer H; Nielsen CB; Pedersen EB
J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
[TBL] [Abstract][Full Text] [Related]
38. Effects of alpha-human atrial natriuretic peptide on the interrelationship of arterial pressure, aortic nerve activity, and aortic diameter.
Hirooka Y; Takeshita A; Imaizumi T; Nakamura N; Tomoike H; Nakamura M
Circ Res; 1988 Dec; 63(6):987-96. PubMed ID: 2973847
[TBL] [Abstract][Full Text] [Related]
39. Microvascular effects of atrial natriuretic peptide (ANP) in man: studies during high and low salt diet.
Houben AJ; Krekels MM; Schaper NC; Fuss-Lejeune MJ; Rodriguez SA; de Leeuw PW
Cardiovasc Res; 1998 Aug; 39(2):442-50. PubMed ID: 9798529
[TBL] [Abstract][Full Text] [Related]
40. Maintenance of forearm vasodilator action of atrial natriuretic factor in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Kubo SH; Atlas SA; Laragh JH; Cody RJ
Am J Cardiol; 1992 May; 69(16):1306-9. PubMed ID: 1533988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
